Cancer stem cells, bone and tumor microenvironment: Key players in bone metastases

Ilaria Roato, Riccardo Ferracini

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Tumor mass is constituted by a heterogeneous group of cells, among which a key role is played by the cancer stem cells (CSCs), possessing high regenerative properties. CSCs directly metastasize to bone, since bone microenvironment represents a fertile environment that protects CSCs against the immune system, and maintains their properties and plasticity. CSCs can migrate from the primary tumor to the bone marrow (BM), due to their capacity to perform the epithelial-to-mesenchymal transition. Once in BM, they can also perform the mesenchymal-to-epithelial transition, allowing them to proliferate and initiate bone lesions. Another factor explaining the osteotropism of CSCs is their ability to recognize chemokine gradients toward BM, through the CXCL12–CXCR4 axis, also known to be involved in tumor metastasis to other organs. Moreover, the expression of CXCR4 is associated with the maintenance of CSCs’ stemness, and CXCL12 expression by osteoblasts attracts CSCs to the BM niches. CSCs localize in the pre-metastatic niches, which are anatomically distinct regions within the tumor microenvironment and govern the metastatic progression. According to the stimuli received in the niches, CSCs can remain dormant for long time or outgrow from dormancy and create bone lesions. This review resumes different aspects of the CSCs’ bone metastastic process and discusses available treatments to target CSCs.

Original languageEnglish
Article number56
JournalCancers
Volume10
Issue number2
DOIs
Publication statusPublished - Feb 20 2018

Fingerprint

Stem Cell Niche
Tumor Microenvironment
Neoplastic Stem Cells
Neoplasm Metastasis
Bone and Bones
Bone Marrow
Epithelial-Mesenchymal Transition
Neoplasms
Osteoblasts
Chemokines
Immune System

Keywords

  • Bone metastases
  • Cancer stem cells
  • Osteotropism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cancer stem cells, bone and tumor microenvironment : Key players in bone metastases. / Roato, Ilaria; Ferracini, Riccardo.

In: Cancers, Vol. 10, No. 2, 56, 20.02.2018.

Research output: Contribution to journalReview article

@article{1eb4d27740be4d56bef40420f68bbe08,
title = "Cancer stem cells, bone and tumor microenvironment: Key players in bone metastases",
abstract = "Tumor mass is constituted by a heterogeneous group of cells, among which a key role is played by the cancer stem cells (CSCs), possessing high regenerative properties. CSCs directly metastasize to bone, since bone microenvironment represents a fertile environment that protects CSCs against the immune system, and maintains their properties and plasticity. CSCs can migrate from the primary tumor to the bone marrow (BM), due to their capacity to perform the epithelial-to-mesenchymal transition. Once in BM, they can also perform the mesenchymal-to-epithelial transition, allowing them to proliferate and initiate bone lesions. Another factor explaining the osteotropism of CSCs is their ability to recognize chemokine gradients toward BM, through the CXCL12–CXCR4 axis, also known to be involved in tumor metastasis to other organs. Moreover, the expression of CXCR4 is associated with the maintenance of CSCs’ stemness, and CXCL12 expression by osteoblasts attracts CSCs to the BM niches. CSCs localize in the pre-metastatic niches, which are anatomically distinct regions within the tumor microenvironment and govern the metastatic progression. According to the stimuli received in the niches, CSCs can remain dormant for long time or outgrow from dormancy and create bone lesions. This review resumes different aspects of the CSCs’ bone metastastic process and discusses available treatments to target CSCs.",
keywords = "Bone metastases, Cancer stem cells, Osteotropism",
author = "Ilaria Roato and Riccardo Ferracini",
year = "2018",
month = "2",
day = "20",
doi = "10.3390/cancers10020056",
language = "English",
volume = "10",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI AG",
number = "2",

}

TY - JOUR

T1 - Cancer stem cells, bone and tumor microenvironment

T2 - Key players in bone metastases

AU - Roato, Ilaria

AU - Ferracini, Riccardo

PY - 2018/2/20

Y1 - 2018/2/20

N2 - Tumor mass is constituted by a heterogeneous group of cells, among which a key role is played by the cancer stem cells (CSCs), possessing high regenerative properties. CSCs directly metastasize to bone, since bone microenvironment represents a fertile environment that protects CSCs against the immune system, and maintains their properties and plasticity. CSCs can migrate from the primary tumor to the bone marrow (BM), due to their capacity to perform the epithelial-to-mesenchymal transition. Once in BM, they can also perform the mesenchymal-to-epithelial transition, allowing them to proliferate and initiate bone lesions. Another factor explaining the osteotropism of CSCs is their ability to recognize chemokine gradients toward BM, through the CXCL12–CXCR4 axis, also known to be involved in tumor metastasis to other organs. Moreover, the expression of CXCR4 is associated with the maintenance of CSCs’ stemness, and CXCL12 expression by osteoblasts attracts CSCs to the BM niches. CSCs localize in the pre-metastatic niches, which are anatomically distinct regions within the tumor microenvironment and govern the metastatic progression. According to the stimuli received in the niches, CSCs can remain dormant for long time or outgrow from dormancy and create bone lesions. This review resumes different aspects of the CSCs’ bone metastastic process and discusses available treatments to target CSCs.

AB - Tumor mass is constituted by a heterogeneous group of cells, among which a key role is played by the cancer stem cells (CSCs), possessing high regenerative properties. CSCs directly metastasize to bone, since bone microenvironment represents a fertile environment that protects CSCs against the immune system, and maintains their properties and plasticity. CSCs can migrate from the primary tumor to the bone marrow (BM), due to their capacity to perform the epithelial-to-mesenchymal transition. Once in BM, they can also perform the mesenchymal-to-epithelial transition, allowing them to proliferate and initiate bone lesions. Another factor explaining the osteotropism of CSCs is their ability to recognize chemokine gradients toward BM, through the CXCL12–CXCR4 axis, also known to be involved in tumor metastasis to other organs. Moreover, the expression of CXCR4 is associated with the maintenance of CSCs’ stemness, and CXCL12 expression by osteoblasts attracts CSCs to the BM niches. CSCs localize in the pre-metastatic niches, which are anatomically distinct regions within the tumor microenvironment and govern the metastatic progression. According to the stimuli received in the niches, CSCs can remain dormant for long time or outgrow from dormancy and create bone lesions. This review resumes different aspects of the CSCs’ bone metastastic process and discusses available treatments to target CSCs.

KW - Bone metastases

KW - Cancer stem cells

KW - Osteotropism

UR - http://www.scopus.com/inward/record.url?scp=85042306899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042306899&partnerID=8YFLogxK

U2 - 10.3390/cancers10020056

DO - 10.3390/cancers10020056

M3 - Review article

AN - SCOPUS:85042306899

VL - 10

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 2

M1 - 56

ER -